<DOC>
	<DOCNO>NCT00986323</DOCNO>
	<brief_summary>The purpose study determine whether nocturnal environmental control Temperature control Laminar Airflow ( TLA ) effective add treatment patient perennial allergic asthma .</brief_summary>
	<brief_title>Efficacy Study Temperature Controlled Laminar Airflow ( TLA ) -Treatment Perennial Allergic Asthma</brief_title>
	<detailed_description>Exposure inhale allergen pathogenetic factor allergic asthma . However , physical , chemical combine method aim reduce airborne allergen level show little effect reduce asthma symptom people sensitive perennial allergens.Aims objective : This study aim investigate treatment Temperature control Laminar Airflow ( TLA ) low particle concentration direct breathe zone subject allergic asthma night sleep . The hypothesis decrease allergen exposure night effect quality life bronchial inflammation . Method : This multicentre , double blind , randomize 52 week parallel trial compare active TLA treatment Placebo . For ethical reason randomization 2 1 active placebo treatment , respectively . A 2 week run-in period insert inclusion randomization , patient shall get familiar use patient asthma diary adhere requirement study participation . First 12 week unchanged maintenance medication keep week 13-52 medication modify obtain asthma control accord international guideline ( GINA ) . After inclusion , run-in , randomization baseline measurement active/placebo treatment AA implement 52 week .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Consent participate voluntarily . Willing able comply study specific procedure . Signed Informed Consent prior study procedure . Perennial allergic asthma , male female , age 7 70 year , time randomization . A miniAQLQ/PAQLQ score ≤ 5.5 . Sensitive pet allergen and/or house dust mite demonstrate change RAST 0.70 positive skin prick test ( wheal reaction similar histamine control ) . Daily maintenance dose least ICS ≥200µg/day budesonide ≥100µg/day fluticasone since least 6 month Features partly control asthma accord GINA Current smoker ( Nonsmoker define abstinent since &gt; 1 year ) . Children : Parents'indoor smoking . Participation another allergen avoidance program Participation drug trial precede 3 month Multiple chemical sensitivity ( e.g . paint , petrol , perfume ) primary etiology Allergen injection sublingual treatment precede 2 year ICS ≥1200µg/day budesonide 1000µg/day fluticasone Significant cardiovascular disease Participation present trial family member within household Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Temperature control Laminar Airflow</keyword>
	<keyword>TLA</keyword>
	<keyword>Perennial allergy</keyword>
	<keyword>Quality life</keyword>
	<keyword>Environmental control</keyword>
</DOC>